INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH

icddr,b’s research led to WHO approval of Cecolin, a single-dose HPV vaccine, aiding global cervical cancer prevention. The CVIA 087 trial in Ghana demonstrated Cecolin’s safety and efficacy, offering a solution for vaccine shortages in low- and middle-income countries. WHO Director-General Dr Tedros Adhanom Ghebreyesus emphasized the potential to eliminate cervical cancer through vaccination.

DEN-2 virus dominates Bangladesh's dengue cases; a tetravalent dengue vaccine candidate, TV005, shows promise but faces funding challenges for Phase III trials. Despite reduced patient influx compared to last year, vigilance is crucial due to varying immunity levels across regions.